Entrada Therapeutics Inc (TRDA)
Cost of Revenue
$40.05M
TTM · Period ending: · USD
TRDA Cost of Revenue
Latest reported$40.05Mperiod ending
Latest reported$40.05Mperiod ending
TRDA Cost of Revenue ($104.00K → $40.05M)
Annual cost of revenue
High-resolution chart · PNG
TRDA cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 4,096,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 326,000 | |
| 104,000 |